Ionis Pharmaceuticals Touts $3B TRYNGOLZA Opportunity, Pipeline Readouts at Conference Executives at a healthcare investor event outlined commercial launch plans, pipeline readouts and market-development priorities across several biotechnology franchises, with discussion spanning Ionis Pharmaceuticals (
NASDAQ:IONS ) products including TRYNGOLZA, DAWNZERA and WAINUA, as well as Neurocri
Better Buy: Micron or Nvidia Stock Nvidia and Micron are both benefiting from artificial intelligence (AI) spending.
Inflation Could Hit 6% This Summer. Here's What That Means for Your Wallet Q2 inflation forecasts just jumped from 2.7% to 6%. Don't panic -- but do move your cash somewhere it earns more than 0.01%.
Better Buy: Starbucks vs. Dutch Bros Stock Starbucks stock is thriving right now, while Dutch Bros stock is struggling.
Is Amazon Starting an Nvidia-Style Run? Amazon stock has jumped more than 30% since late March.
The Quantum Computing IPO Wall Street Hasn't Figured Out Yet -- but Should in 2026 Quantinuum filed its S-1 with the Securities and Exchange Commission (SEC) earlier this month.
Rocket Lab vs. SpaceX: Which Stock is the Better Aerospace Buy? Investors could have astronomical opportunities with Rocket Lab and SpaceX.
